Vitro Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Vitro Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2022 to Q2 2024.
Vitro Biopharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending July 31, 2024 was $259K, a 8.92% decline year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$259K	-$25.4K	-8.92%	Jul 31, 2024	10-Q	2024-09-16
Q1 2024	$267K	+$33.3K	+14.2%	Apr 30, 2024	10-Q	2024-05-31
Q4 2023	$274K	+$36.3K	+15.3%	Jan 31, 2024	10-Q	2024-03-14
Q3 2023	$281K			Oct 31, 2023	10-K	2024-01-29
Q2 2023	$284K			Jul 31, 2023	10-Q	2023-08-28
Q1 2023	$234K			Apr 30, 2023	10-Q	2023-06-13
Q4 2022	$238K			Jan 31, 2023	10-Q	2023-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.